** Shares of Aroa Biosurgery ARX.AX fall 18.1% to A$0.655, on track for their biggest-ever intraday drop
** Wound healing products maker fell as much as 19.1% earlier in the day, hitting lowest level since Dec. 18
** Co cuts FY25 normalised EBITDA profit guidance to a range between NZ$2 mln ($1.13 mln) and NZ$4 mln, from earlier guidance of NZ$2 mln to NZ$6 mln
** Cuts FY25 total revenue guidance to between NZ$81 mln and NZ$84 mln from earlier guidance of NZ$80 mln to NZ$87 mln
** About 901,488 shares change hand, compared to 30-day average trading volume of 318,195 shares
** Stock down around 15% this year, including the day's moves
($1 = 1.7680 New Zealand dollars)
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。